C24.0 Malignant neoplasm of extrahepatic bile duct

✓ Billable ICD-10-CM 2026
Open C24.0 in Web App →

The ICD-10-CM code for Malignant neoplasm of extrahepatic bile duct is C24.0 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
C15-C26: Malignant neoplasms of digestive organs (C15-C26)
Category C24
5 codes (4 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C24.0:

  • Klatskin's tumor
  • Tumor › Klatskin's

Inclusion Terms

  • Malignant neoplasm of biliary duct or passage NOS
  • Malignant neoplasm of common bile duct
  • Malignant neoplasm of cystic duct
  • Malignant neoplasm of hepatic duct

U.S. Hospital Utilization

  • An estimated 4,525 U.S. inpatient stays in 2023 included C24.0 among the documented diagnoses.
  • 1,780 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial